DRYQX
Price
$19.91
Change
-$0.26 (-1.29%)
Updated
Jun 13 closing price
Net Assets
1.58B
RGEBX
Price
$74.89
Change
-$0.91 (-1.20%)
Updated
Jun 13 closing price
Net Assets
306.22B
Interact to see
Advertisement

DRYQX vs RGEBX

Header iconDRYQX vs RGEBX Comparison
Open Charts DRYQX vs RGEBXBanner chart's image
BNY Mellon Research Growth Y
Price$19.91
Change-$0.26 (-1.29%)
VolumeN/A
Net Assets1.58B
American Funds Growth Fund of Amer R2E
Price$74.89
Change-$0.91 (-1.20%)
VolumeN/A
Net Assets306.22B
DRYQX vs RGEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DRYQX vs. RGEBX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRYQX is a StrongBuy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 306B vs. DRYQX (1.58B). DRYQX (0.00) and RGEBX (0.00) have matching dividends . DRYQX was incepted earlier than RGEBX: DRYQX (12 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than DRYQX (0.80). DRYQX is a more actively managed with annual turnover of: 27.94 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than DRYQX: RGEBX (250) vs DRYQX (1000000). RGEBX annual gain was more profitable for investors over the last year : 7.68 vs. DRYQX (2.63). RGEBX return over 5 years is better than : 45.42 vs. DRYQX (20.12).
DRYQXRGEBXDRYQX / RGEBX
Total Expense Ratio0.781.0972%
Annual Report Gross Expense Ratio0.801.0973%
Fund Existence12 years11 years-
Gain YTD-1.3384.829-28%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.58B306B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year2.637.6834%
Returns for 3 years43.0351.0184%
Returns for 5 years20.1245.4244%
Returns for 10 years36.1665.8755%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APGE44.482.62
+6.26%
Apogee Therapeutics
VVOS2.140.01
+0.47%
Vivos Therapeutics
SJM95.72-1.65
-1.69%
JM Smucker Company (The)
ELVA3.38-0.17
-4.79%
Electrovaya
NNDM1.44-0.12
-7.69%
Nano Dimension Ltd